Provided by Tiger Fintech (Singapore) Pte. Ltd.

ACADIA Pharmaceuticals

14.73
-0.1000-0.67%
Pre-market: 14.890.1600+1.09%04:03 EDT
Volume:957.58K
Turnover:14.07M
Market Cap:2.46B
PE:10.83
High:14.83
Open:14.79
Low:14.47
Close:14.83
Loading ...

Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 7, 2025

Business Wire
·
24 Apr

TD Cowen Sticks to Its Buy Rating for ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
23 Apr

BofA Adjusts Price Target on ACADIA Pharmaceuticals to $18 From $19, Keeps Neutral Rating

MT Newswires Live
·
17 Apr

ACADIA Pharmaceuticals Inc : Bmo Cuts Target Price to $24 From $31

THOMSON REUTERS
·
17 Apr

Declining Stock and Solid Fundamentals: Is The Market Wrong About ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)?

Simply Wall St.
·
13 Apr

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
12 Apr

ACADIA Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham

Dow Jones
·
08 Apr

RBC Capital Sticks to Its Buy Rating for ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
05 Apr

Why Is Acadia (ACAD) Down 11.1% Since Last Earnings Report?

Zacks
·
28 Mar

SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug

Zacks
·
27 Mar

Soleno jumps as analysts say US nod for rare disease drug transforms treatment options

Reuters
·
27 Mar

Is ACADIA Pharmaceuticals Inc. (ACAD) a Promising Biotech Stock According to Wall Street Analysts

Insider Monkey
·
26 Mar

Is ACADIA Pharmaceuticals Inc. (ACAD) the Best Nasdaq Stock Under $20 to Buy Now?

Insider Monkey
·
18 Mar

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
15 Mar

Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?

Zacks
·
14 Mar

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences

Business Wire
·
14 Mar

Acadia Pharmaceuticals assumed with an Equal Weight at Morgan Stanley

TIPRANKS
·
07 Mar

Balanced Outlook for ACADIA Pharmaceuticals Amid Uncertain Long-term Growth Prospects

TIPRANKS
·
07 Mar

ACADIA Pharmaceuticals Director Makes Significant Stock Sale

TIPRANKS
·
07 Mar

Clinical Data from Open-Label DAFFODIL™ Study Evaluating Long-term Safety of DAYBUE® (trofinetide) in Patients with Rett Syndrome Published in Med

Business Wire
·
05 Mar